Survival curve indicated that higher expression level of TPX2 was significantly associated with sPRCC2 patients’ overall survival (Fig. 3E) and it is also correlated with higher clinical stage, tumor T stage and N stage (Fig. 3F-H). Here, TPX2 is linked to neoplasm.